Construction and validity testing of an ultrasound artificial intelligence diagnosis platform for breast diseases

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043427

Enrollment

Unknown

Registered

2021-02-16

Start date

2018-11-01

Completion date

Unknown

Last updated

2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Gold Standard:Pathological diagnosis

Index test:Multiparametric&#32

breast&#32

ultrasound&#32

(with&#32

Radiomic&#32

features).

Eligibility

Sex/Gender

Female

Age

18 Years to 89 Years

Inclusion criteria

Inclusion criteria: (1) Patients with breast masses on examinations such as ultrasound, mammography or MRI of any kind, especially BI-RADS category 3 and 4 patients; (2) Informed of this study, and signed an informed consent form. Voluntary shear wave elastography examination; (3) Agreed and combined with puncture biopsy, rotary biopsy, or surgical treatment, and finally obtained the pathological diagnosis.

Exclusion criteria

Exclusion criteria: (1) Pregnancy or lactation; (2) implants in the breast; (3) history of surgery on the affected side; (4) history of malignant tumor and other cachexia.

Design outcomes

Primary

Measure	Time frame
Radiomic features;Emax;Emin;Emean;PSV;RI;Size;Histological type;Molecular subtypes;	—

Countries

America

Contacts

Public ContactJing Pei

The First Affiliated Hospital of Anhui Medical University

peijing@ahmu.edu.cn+86 13966668272

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026